Comparison of zinc oxide eugenol and metapex as root canal filling material following pulpectomy in primary molars

Phase 3

• Conditions: Symptomatic irreversible pulpitis; Pulpal necrosis; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12623000785606
• Lead Sponsor: Sana Ashfaq

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-07-19
• Last Update Posted: 25 July 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. Age groups:4-9 years
2. History of spontaneous pain due to caries
3. Teeth with clinical signs of either chronic irreversible pulpitis or pulp necrosis such as gingival swelling or sinus tract/purulence or mild pathological mobility
4. Continuous bleeding after amputation of coronal pulp
5. Physiological or pathological external root resorption limited to apical third and with at least two-thirds root intact.

Exclusion Criteria

1. Nonrestorable teeth.
2. Teeth exhibiting grade 2 or grade 3 mobility.
3. Teeth demonstrating extensive external/internal resorption.
4. Teeth with reversible pulpitis
5. Children having some congenital abnormalities.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of clinical and radiographic symptoms following use of zinc oxide eugenol or metapex in primary molars<br>1. Pain - will be assessed through VAS scale[At 6 months after treatment ];Tenderness - through palpation[At 6 months after treatment];Draining fistula -on intraoral examintion[At 6 months after treatment]

Secondary Outcome Measures

Name	Time	Method
Evaluation of clinical and radiographic symptoms following use of zinc oxide eugenol or metapex in primary molars<br>1. Change in size of periapical radiolucency[Immediately post operative<br>At 3 months<br>At 6 months];2. Presence or absence of external or internal resorption[Immediately post operative<br>At 3 months<br>At 6 months];Presence or absence of any pathology for example cyst[Immediately post operative<br>At 3 months<br>At 6 months]